Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 37870536

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2024 Jan 1
First author
Meric-Bernstam F

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2023 Dec 12;13(12):OF10. doi: 10.1158/2159-8290.CD-ND2023-0013.
    note
    Source null
    related pmid
    37888905
    relationship
    Comment in

Authors and identifiers

  1. name
    Meric-Bernstam F
    type
    Author
  2. name
    Makker V
    type
    Author
  3. name
    Oaknin A
    type
    Author
  4. name
    Oh DY
    type
    Author
  5. name
    Banerjee S
    type
    Author
  6. name
    González-Martín A
    type
    Author
  7. name
    Jung KH
    type
    Author
  8. name
    Ługowska I
    type
    Author
  9. name
    Manso L
    type
    Author
  10. name
    Manzano A
    type
    Author
  11. name
    Melichar B
    type
    Author
  12. name
    Siena S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Meric-Bernstam F
    type
    Author
  2. name
    Makker V
    type
    Author
  3. name
    Oaknin A
    type
    Author
  4. name
    Oh DY
    type
    Author
  5. name
    Banerjee S
    type
    Author
  6. name
    González-Martín A
    type
    Author
  7. name
    Jung KH
    type
    Author
  8. name
    Ługowska I
    type
    Author
  9. name
    Manso L
    type
    Author
  10. name
    Manzano A
    type
    Author
  11. name
    Melichar B
    type
    Author
  12. name
    Siena S
    type
    Author
bibliography ids
  1. nci-bib-b46c3eb933cd161be3cfc2ba
book metadata
content sha256
54b9ca85dda2b7bdd53dfe3ab54d8b19dfcddadfab8b41f17b41fd5314b0b35a
document type
citation
dois
  1. 10.1200/JCO.23.02005
electronic publication date
display
2023 Oct 23
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:37870536
immutable id
pubmed:37870536@54b9ca85dda2b7bdd53dfe3ab54d8b19dfcddadfab8b41f17b41fd5314b0b35a
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
1
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
47-58
volume
42
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2023 Dec 12;13(12):OF10. doi: 10.1158/2159-8290.CD-ND2023-0013.
    note
    Source null
    related pmid
    37888905
    relationship
    Comment in
outcomes validated
false
pmid
37870536
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
0d00af73b9d67cf548ba3cb7169754336e12909014cffcde549c84bba5c93a55
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2024 Jan 1
precision
day
year
2024
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
  4. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/37870536/
title
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial.

Preserved source evidence · Independent clinical review pending · Not medical advice